Literature DB >> 21441072

Dietary therapies for epilepsy: future research.

Sudha K Kessler1, Elizabeth G Neal, Carol S Camfield, Eric H Kossoff.   

Abstract

Since 1921, dietary therapies have remained valuable options in the treatment of intractable childhood epilepsy. The traditional ketogenic diet has been well demonstrated, including in a recent randomized, controlled trial, as being highly effective. More recent alternative diets such as the medium-chain triglyceride diet, modified Atkins diet, and low-glycemic-index treatment have expanded the use of this modality to more children as well as adults. In this review, we discuss our top 10 most pressing research topics related to the ketogenic diet that warrant future study. As well, two promising ketogenic diet clinical researchers discuss their past and current research to help answer some of these questions.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21441072      PMCID: PMC5776748          DOI: 10.1016/j.yebeh.2011.02.018

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  56 in total

1.  Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month.

Authors:  Eric H Kossoff; Jennifer L Dorward; Zahava Turner; Paula L Pyzik
Journal:  J Child Neurol       Date:  2010-09-10       Impact factor: 1.987

2.  Ketogenic diet in patients with myoclonic-astatic epilepsy.

Authors:  Roberto Horacio Caraballo; Ricardo Oscar Cersósimo; Diego Sakr; Araceli Cresta; Nidia Escobal; Natalio Fejerman
Journal:  Epileptic Disord       Date:  2006-06       Impact factor: 1.819

3.  Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants.

Authors:  Amanda M Hong; Zahava Turner; Rana F Hamdy; Eric H Kossoff
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

4.  Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy.

Authors:  A G Christina Bergqvist; Joan I Schall; Paul R Gallagher; Avital Cnaan; Virginia A Stallings
Journal:  Epilepsia       Date:  2005-11       Impact factor: 5.864

5.  Long-term use of the ketogenic diet in the treatment of epilepsy.

Authors:  Darcy K Groesbeck; Renee M Bluml; Eric H Kossoff
Journal:  Dev Med Child Neurol       Date:  2006-12       Impact factor: 5.449

6.  Carnitine levels and the ketogenic diet.

Authors:  E Berry-Kravis; G Booth; A C Sanchez; J Woodbury-Kolb
Journal:  Epilepsia       Date:  2001-11       Impact factor: 5.864

7.  Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood.

Authors:  H Oguni; T Tanaka; K Hayashi; M Funatsuka; M Sakauchi; S Shirakawa; M Osawa
Journal:  Neuropediatrics       Date:  2002-06       Impact factor: 1.947

Review 8.  Ketone bodies as a therapeutic for Alzheimer's disease.

Authors:  Samuel T Henderson
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

9.  A pilot trial with modified Atkins' diet in adult patients with refractory epilepsy.

Authors:  Evelien Carrette; Kristl Vonck; Veerle de Herdt; Isabelle Dewaele; Robrecht Raedt; Lut Goossens; Michel Van Zandijcke; Wytse Wadman; Vijay Thadani; Paul Boon
Journal:  Clin Neurol Neurosurg       Date:  2008-06-24       Impact factor: 1.876

10.  Ketogenic diet: electrophysiological effects on the normal human cortex.

Authors:  Roberto Cantello; Claudia Varrasi; Roberto Tarletti; Michela Cecchin; Federico D'Andrea; Pierangelo Veggiotti; Giorgio Bellomo; Francesco Monaco
Journal:  Epilepsia       Date:  2007-06-11       Impact factor: 5.864

View more
  17 in total

1.  FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice.

Authors:  Kerstin Stemmer; Fabio Zani; Kirk M Habegger; Christina Neff; Petra Kotzbeck; Michaela Bauer; Suma Yalamanchilli; Ali Azad; Maarit Lehti; Paulo J F Martins; Timo D Müller; Paul T Pfluger; Randy J Seeley
Journal:  Diabetologia       Date:  2015-06-23       Impact factor: 10.122

2.  Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression.

Authors:  Victoire Gouirand; Tristan Gicquel; Evan C Lien; Emilie Jaune-Pons; Quentin Da Costa; Pascal Finetti; Elodie Metay; Camille Duluc; Jared R Mayers; Stephane Audebert; Luc Camoin; Laurence Borge; Marion Rubis; Julie Leca; Jeremy Nigri; François Bertucci; Nelson Dusetti; Juan L Iovanna; Richard Tomasini; Ghislain Bidaut; Fabienne Guillaumond; Matthew G Vander Heiden; Sophie Vasseur
Journal:  EMBO J       Date:  2022-03-21       Impact factor: 14.012

3.  Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acids.

Authors:  Kelly L Gorres; Derek Daigle; Sudharshan Mohanram; George Miller
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

4.  βOHB Protective Pathways in Aralar-KO Neurons and Brain: An Alternative to Ketogenic Diet.

Authors:  Irene Pérez-Liébana; María José Casarejos; Andrea Alcaide; Eduardo Herrada-Soler; Irene Llorente-Folch; Laura Contreras; Jorgina Satrústegui; Beatriz Pardo
Journal:  J Neurosci       Date:  2020-10-21       Impact factor: 6.167

5.  The ketogenic diet as a treatment paradigm for diverse neurological disorders.

Authors:  Carl E Stafstrom; Jong M Rho
Journal:  Front Pharmacol       Date:  2012-04-09       Impact factor: 5.810

6.  A ketogenic diet may offer neuroprotection in glaucoma and mitochondrial diseases of the optic nerve.

Authors:  Tomasz Zarnowski; Maria Tulidowicz-Bielak; Ewa Kosior-Jarecka; Iwona Zarnowska; Waldemar A Turski; Maciej Gasior
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2012

Review 7.  Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.

Authors:  A Paoli; A Rubini; J S Volek; K A Grimaldi
Journal:  Eur J Clin Nutr       Date:  2013-06-26       Impact factor: 4.016

Review 8.  The Mutual Interaction Between Sleep and Epilepsy on the Neurobiological Basis and Therapy.

Authors:  Yi-Qun Wang; Meng-Qi Zhang; Rui Li; Wei-Min Qu; Zhi-Li Huang
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Muscle PGC-1α is required for long-term systemic and local adaptations to a ketogenic diet in mice.

Authors:  Svenia Schnyder; Kristoffer Svensson; Bettina Cardel; Christoph Handschin
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-02-21       Impact factor: 4.310

Review 10.  Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis.

Authors:  Hai-Feng Li; Yan Zou; Gangqiang Ding
Journal:  Iran J Pediatr       Date:  2013-12       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.